Blog
RSS FeedPosted by Michael Wonder on 19 Jul 2022
German Government announces bill to drastically slash drug reimbursement
19 July 2022 - On 8 July 2022, the German Health Ministry has officially shared the second edition of a new ...
Posted by Michael Wonder on 04 Apr 2022
Bluebird Bio has serious cash flow concerns; inability to strike reimbursement deals in Europe partly to blame
3 April 2022 - Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic ...
Posted by Michael Wonder on 20 Aug 2015
Afatinib: added benefit in certain mutations confirmed by IQWiG
17 August 2015 - Afatinib dimaleate (trade name: Giotrif) has been approved since September 2013 for the treatment of adult patients ...